Ying Zhang

7PUBLICATIONS
25CO-AUTHORS
Tumour immunologyEpigenetics (incl. genome methylation and epigenomics)Cancer therapy (excl. chemotherapy and radiation therapy)Proteins and peptidesMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Nov 29, 2025
Innate immunity in tumour immunoediting and immunosurveillance.

Zhibin Zhang, Ying Zhang, Judy Lieberman

|Aug 21, 2024
Tumor editing suppresses innate and adaptive antitumor immunity and is reversed by inhibiting DNA methylation.

Ying Zhang, Pourya Naderi Yeganeh, Haiwei Zhang

|Apr 05, 2023
The NK cell receptor NKp46 recognizes ecto-calreticulin on ER-stressed cells.

Sumit Sen Santara, Dian-Jang Lee, Ângela Crespo

|Feb 12, 2022
Targeting stem-loop 1 of the SARS-CoV-2 5' UTR to suppress viral translation and Nsp1 evasion.

Setu M Vora, Pietro Fontana, Tianyang Mao

|Feb 25, 2021
Immunotherapy for breast cancer using EpCAM aptamer tumor-targeted gene knockdown.

Ying Zhang, Xuemei Xie, Pourya Naderi Yeganeh

|May 06, 2020
FDA-approved disulfiram inhibits pyroptosis by blocking gasdermin D pore formation.

Jun Jacob Hu, Xing Liu, Shiyu Xia

Pageof 2